Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16/18 vaccine
- Author
- GOLDIE, Sue J1 ; KOHLI, Michele2 ; GRIMA, Daniel2 ; WEINSTEIN, Milton C1 3 ; WRIGHT, Thomas C4 ; BOSCH, F. Xavier5 ; FRANCO, Eduardo6
[1] Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, United States
[2] Innovus Research Inc., Burlington, Ontario, Canada
[3] Innovus Research (U.S.) Inc., Medford, MA, United States
[4] Department of Pathology, Columbia University School of Medi- cine, New York, NY, United States
[5] Catalan Institute of Oncology, Barcelona, Spain
[6] Departments of Epidemiology and Oncology, McGill University, Montreal, Quebec, Canada - Source
Journal of the National Cancer Institute. 2004, Vol 96, Num 8, pp 604-615, 12 p ; ref : 115 ref
- ISSN
- 0027-8874
- Scientific domain
- Medical oncology
- Publisher
- Oxford University Press, Cary, NC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Analyse coût efficacité Cancérologie Homme Immunoprophylaxie Modèle Markov Modèle statistique Papillomavirus humain 16 Papillomavirus humain 18 Prévention Vaccin Virose Cancer du col de l'utérus Etats Unis Appareil génital femelle pathologie Col utérus pathologie Economie santé Infection Papillomavirus humain Papillomavirus Papovaviridae Santé publique Tumeur maligne Virus Amérique du Nord Amérique
- Keyword (en)
- Cost efficiency analysis Cancerology Human Immunoprophylaxis Markov model Statistical model Human papillomavirus 16 Human papillomavirus 18 Prevention Vaccine Viral disease Cervical cancer United States Female genital diseases Uterine cervix diseases Health economy Infection Human papillomavirus Papillomavirus Papovaviridae Public health Malignant tumor Virus North America America
- Keyword (es)
- Análisis costo eficacia Cancerología Hombre Inmunoprofilaxia Modelo Markov Modelo estadístico Human papillomavirus 16 Human papillomavirus 18 Prevención Vacuna Virosis Estados Unidos Aparato genital hembra patología Cuello útero patología Economía salud Infección Human papillomavirus Papillomavirus Papovaviridae Salud pública Tumor maligno Virus America del norte America
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20C Female genital diseases / 002B20C02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16002562
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/jnci/djh104 
https://dx.doi.org/10.1093/jnci/djh104
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djh104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"604\";s:8:\"\u0000*\u0000epage\";s:3:\"615\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GOLDIE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sue J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:14:\"KOHLI, Michele\";i:1;s:13:\"GRIMA, Daniel\";i:2;s:19:\"WEINSTEIN, Milton C\";i:3;s:16:\"WRIGHT, Thomas C\";i:4;s:16:\"BOSCH, F. Xavier\";i:5;s:15:\"FRANCO, Eduardo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djh104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"604\";s:8:\"\u0000*\u0000epage\";s:3:\"615\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GOLDIE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sue J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:14:\"KOHLI, Michele\";i:1;s:13:\"GRIMA, Daniel\";i:2;s:19:\"WEINSTEIN, Milton C\";i:3;s:16:\"WRIGHT, Thomas C\";i:4;s:16:\"BOSCH, F. Xavier\";i:5;s:15:\"FRANCO, Eduardo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djh104\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djh104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"604\";s:8:\"\u0000*\u0000epage\";s:3:\"615\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GOLDIE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sue J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:14:\"KOHLI, Michele\";i:1;s:13:\"GRIMA, Daniel\";i:2;s:19:\"WEINSTEIN, Milton C\";i:3;s:16:\"WRIGHT, Thomas C\";i:4;s:16:\"BOSCH, F. Xavier\";i:5;s:15:\"FRANCO, Eduardo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djh104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"604\";s:8:\"\u0000*\u0000epage\";s:3:\"615\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GOLDIE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sue J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:14:\"KOHLI, Michele\";i:1;s:13:\"GRIMA, Daniel\";i:2;s:19:\"WEINSTEIN, Milton C\";i:3;s:16:\"WRIGHT, Thomas C\";i:4;s:16:\"BOSCH, F. Xavier\";i:5;s:15:\"FRANCO, Eduardo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1093\/jnci\/djh104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:9:\"\u0000*\u0000jtitle\";s:40:\"Journal of the National Cancer Institute\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Natl. Cancer Inst\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"604\";s:8:\"\u0000*\u0000epage\";s:3:\"615\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0027-8874\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GOLDIE\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Sue J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:14:\"KOHLI, Michele\";i:1;s:13:\"GRIMA, Daniel\";i:2;s:19:\"WEINSTEIN, Milton C\";i:3;s:16:\"WRIGHT, Thomas C\";i:4;s:16:\"BOSCH, F. Xavier\";i:5;s:15:\"FRANCO, Eduardo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:90:\"Projected clinical benefits and cost-effectiveness of a Human papillomavirus 16\/18 vaccine\";s:8:\"\u0000*\u0000place\";s:8:\"Cary, NC\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
